Investigating the PD-L1:NLRP3 signaling axis as a tumor intrinsic mechanism of adaptive resistance to anti-PD-1 antibody immunotherapy
Administered By
Awarded By
Contributors
- Chan, Francis Ka-Ming Collaborator
- Hanks, Brent A. Principal Investigator
- Jung, Sin-Ho Biostatistician
Start/End
- August 1, 2020 - July 31, 2025